Literature DB >> 10528848

Palliative radiotherapy of appendicular osteosarcoma in 95 dogs.

O Ramirez1, R K Dodge, R L Page, G S Price, M L Hauck, T A LaDue, F Nutter, D E Thrall.   

Abstract

Ninety-five dogs with either a presumptive (n = 24) or biopsy confirmed diagnosis (n = 71) of osteosarcoma received palliative radiotherapy using 60Co photons. Parallel opposed beams were used with each dog receiving either 10 Gy on days 0, 7 and 21 (n = 58) or 8 Gy on days 0 and 7 (n = 37). The 8 Gy fractionation scheme was given with the intent of retreating upon relapse from pain relief. Only 9 of 37 (24%) dogs in the 8 Gy group returned for retreatment. Forty-seven of the 95 dogs (49%) received concurrent or sequential chemotherapy. Seventy of the 95 dogs (74%) experienced pain relief following treatment. In dogs experiencing pain relief the median duration of response was 73 days. Numerous clinical variables were evaluated as predictors of response. The only variable significantly related to achieving a response was the use of chemotherapy. The following variables were significantly related to the duration of response: extent of bone lysis, chemotherapy use, length of bone involved and tumor site (humerus). In a multivariate analysis (n = 73 dogs), after adjusting for chemotherapy use, extent of bone involvement (p = 0.01) and tumor site (p = 0.02) retained statistical significance, while degree of bone lysis did not (p = 0.11). No difference in response incidence or duration was found between 3 fractions of 10 Gy vs. 2 fractions of 8 Gy. Administration of a low initial dose with the intent of retreatment was not a successful strategy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10528848     DOI: 10.1111/j.1740-8261.1999.tb00385.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  13 in total

Review 1.  Palliative radiation therapy for canine osteosarcoma.

Authors:  Monique N Mayer; Candace K Grier
Journal:  Can Vet J       Date:  2006-07       Impact factor: 1.008

Review 2.  Recent and current clinical trials in canine appendicular osteosarcoma.

Authors:  Andrew C Poon; Arata Matsuyama; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

3.  Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 cases (1997-2008).

Authors:  William T N Culp; Francisco Olea-Popelka; Jennifer Sefton; Charles F Aldridge; Stephen J Withrow; Mary H Lafferty; Robert B Rebhun; Michael S Kent; Nicole Ehrhart
Journal:  J Am Vet Med Assoc       Date:  2014-11-15       Impact factor: 1.936

4.  Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010-2019).

Authors:  Beck Ringdahl-Mayland; Douglas H Thamm; Tiffany W Martin
Journal:  Front Vet Sci       Date:  2022-05-10

5.  Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particles.

Authors:  Junko Maeda; Ian M Cartwright; Jeremy S Haskins; Yoshihiro Fujii; Hiroshi Fujisawa; Hirokazu Hirakawa; Mitsuru Uesaka; Hisashi Kitamura; Akira Fujimori; Douglas H Thamm; Takamitsu A Kato
Journal:  Oncol Lett       Date:  2016-06-30       Impact factor: 2.967

Review 6.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

7.  Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs.

Authors:  Megan E Duffy; Christie L Anderson; Kevin Choy; Janean L Fidel
Journal:  Can Vet J       Date:  2018-02       Impact factor: 1.008

8.  Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.

Authors:  Robert J Canter; Steven K Grossenbacher; Jennifer A Foltz; Ian R Sturgill; Jiwon S Park; Jesus I Luna; Michael S Kent; William T N Culp; Mingyi Chen; Jaime F Modiano; Arta M Monjazeb; Dean A Lee; William J Murphy
Journal:  J Immunother Cancer       Date:  2017-12-19       Impact factor: 13.751

Review 9.  Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies.

Authors:  Timothy M Fan; Kimberly A Selting
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

10.  Combination Therapy with Zoledronic Acid and Parathyroid Hormone Improves Bone Architecture and Strength following a Clinically-Relevant Dose of Stereotactic Radiation Therapy for the Local Treatment of Canine Osteosarcoma in Athymic Rats.

Authors:  Ryan C Curtis; James T Custis; Nicole P Ehrhart; E J Ehrhart; Keith W Condon; Sara E Gookin; Seth W Donahue
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.